ArticleFrontiers in plant science2025
ABP-B9, a new strain of
Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Microorganisms are emerging as key agents in sustainable agriculture due to their ability to enhance crop productivity while reducing environmental impact. Among them, Materials and methods: ABP-B9 was evaluated under both field and controlled conditions to assess its plant growth-promoting effects. Parameters such as root development, photosynthetic efficiency, flavonoid content, nitrogen status, and the production of indole-3-acetic acid (IAA) and siderophores were measured. Whole-genome sequencing and phylogenetic analysis were also performed. Results: Field trials showed that ABP-B9 enhanced crop yield in lettuce, spinach, and celery, improving root development, photosynthetic efficiency, flavonoid levels, and nitrogen status. The production of IAA and siderophores was confirmed Discussion: ABP-B9 is a novel, non-pathogenic
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.